SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions DOI Creative Commons
Luis Fernando López Tort, Mia Ferreira de Araújo, Ighor Arantes

et al.

IJID Regions, Journal Year: 2024, Volume and Issue: 14, P. 100503 - 100503

Published: Dec. 4, 2024

Objectives: The SARS-CoV-2 JN.1 lineage emerged in late 2023 and quickly replaced the XBB lineages, becoming predominant Omicron variant worldwide 2024. We estimate epidemiologic impact of this replacement Brazil we further assessed cross-reactive neutralizing antibody (NAb) responses a cohort convalescent Brazilian patients infected during 2023. analyzed evolution lineages severe acute respiratory infection (SARI) cases between July March evaluated NAb to before after with XBB.1* lineages. similar temporal dynamics across all country regions, although its varied locations. southeastern, southern, central-western regions experienced brief wave around October 2023, shortly introduction JN.1, without any immediate upsurge SARI viral replacement. By contrast, northeastern northern did not experience an latter half displayed rapid surge driven by emergence JN.1. found that recent infections population significantly boosted levels against observed second some states likely acted as booster for immunity, providing short-term protection delaying rise certain country.

Language: Английский

Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort study DOI
Yawei Wang, Hau Chi So, Nicole Ngai Yung Tsang

et al.

The Lancet Infectious Diseases, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

3
CD147 mediates S protein pseudovirus of SARS-CoV-2 infection and its induction of spermatogonia apoptosis DOI

Pengyuan Dai,

Chaoye Ma,

Ting Jiang

et al.

Endocrine, Journal Year: 2024, Volume and Issue: 85(3), P. 1435 - 1445

Published: June 1, 2024

Language: Английский

Citations

0
SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions DOI Creative Commons
Luis Fernando López Tort, Mia Ferreira de Araújo, Ighor Arantes

et al.

IJID Regions, Journal Year: 2024, Volume and Issue: 14, P. 100503 - 100503

Published: Dec. 4, 2024

Objectives: The SARS-CoV-2 JN.1 lineage emerged in late 2023 and quickly replaced the XBB lineages, becoming predominant Omicron variant worldwide 2024. We estimate epidemiologic impact of this replacement Brazil we further assessed cross-reactive neutralizing antibody (NAb) responses a cohort convalescent Brazilian patients infected during 2023. analyzed evolution lineages severe acute respiratory infection (SARI) cases between July March evaluated NAb to before after with XBB.1* lineages. similar temporal dynamics across all country regions, although its varied locations. southeastern, southern, central-western regions experienced brief wave around October 2023, shortly introduction JN.1, without any immediate upsurge SARI viral replacement. By contrast, northeastern northern did not experience an latter half displayed rapid surge driven by emergence JN.1. found that recent infections population significantly boosted levels against observed second some states likely acted as booster for immunity, providing short-term protection delaying rise certain country.

Language: Английский

Citations

0